MARINOMED BIOTECH AG

14,35 EUR -0,25 (-1,71%)

Premiumpartner

Firmenbeschreibung

Die Marinomed Biotech AG ist ein österreichisches biopharmazeutisches Unternehmen, das sich auf die Entwicklung innovativer Produkte im Bereich Atemwegs- und Augenerkrankungen spezialisiert, die auf patentgeschützter Technologieplattformen basieren. Das Unternehmen ging 2006 aus einem Spinoff der Veterinärmedizinischen Universität Wien hervor. Die Marinomed Biotech AG ist in der Forschung und Entwicklung tätig und erwirtschaftet Erlöse über die Technologieplattformen und dem Vertrieb der Produkte. Das Unternehmen entwickelte bisher die Plattform Carragelose® sowie die Marinosolv®-Technologieplattform. Carragelose® wird in verschiedenen Produkten zur Behandlung von viralen Infektionen der Atemwege eingesetzt, die nahezu weltweit über Partner vertrieben werden. Mit Marinosolv® kann die Wirksamkeit schwer löslicher Wirkstoffe verbessert werden.

KeyData

endOfFinancialYear: 31.12.2022 00:00
stockholderStructure: Free float (65.9%),Herman Unger (8.1%),Andreas Grassauer CEO (7.9%),Eva Prieschl-Grassauer CSO (7.9%),Abdulmohsen Al Sheikh (5.1%),Mohammed Al Sheikh (5.1%)
sharesOutstanding: 1518194.0000
ceo: Andreas Grassauer
board: Pascal Schmidt, Eva Prieschl-Grassauer
supervisoryBoard: Simon Nebel, Brigitte Ederer, Elisabeth Lackner, Ulrich Kinzel, Eva Hofstaedter-Thalmann
countryID: 1
faceValue: 1.0000
faceValueCurrencyID: 1
faceValueCurrency: EUR
sectorName: Pharmazeutische Industrie
industryName: Gesundheitswesen
subsectorName: Pharmazeutische Industrie
country: Österreich
countryName: Österreich

Kontakt

name: Stephanie Kniep
email: ir@marinomed.com
irWebSite: https://dh3p7.app.goo.gl/nrar

Adresse

street: Hovengasse 25
city: A-2100 Korneuburg
phone: +43-2262-90300
webSite: https://www.marinomed.com/de/
email: office@marinomed.com

Finanzen (kurz)

year: 2021 cash: 5.8000
balanceSheetTotal: 21.3000 liabilities: 21.1000
totalShareholdersEquity: 0.2000 sales: 11.6000
bankLoans: -3.5000 investment: 0.0000
incomeBeforeTaxes: -5.7000 netIncome: -5.9000
cashFlow: -3.4000 employees: 47
currencyID: 1 units: 1000000
currency: EUR
year: 2022 cash: 8.2000
balanceSheetTotal: 22.3000 liabilities: 26.5000
totalShareholdersEquity: -4.1500 sales: 11.2700
investment: 1.2000 incomeBeforeTaxes: -6.4000
netIncome: -6.4000 employees: 49
currencyID: 1 units: 1000000
currency: EUR
year: 2023 cash: 2.5800
balanceSheetTotal: 14.6100 liabilities: 24.7400
totalShareholdersEquity: -10.1300 sales: 9.1800
investment: 0.8600 incomeBeforeTaxes: -6.7900
netIncome: -6.7940 employees: 52
currencyID: 1 units: 1000000
currency: EUR

Finanzen (kurz)

year: 2021
cash: 5.8000
balanceSheetTotal: 21.3000
liabilities: 21.1000
totalShareholdersEquity: 0.2000
sales: 11.6000
bankLoans: -3.5000
investment: 0.0000
incomeBeforeTaxes: -5.7000
netIncome: -5.9000
cashFlow: -3.4000
employees: 47
currencyID: 1
units: 1000000
currency: EUR
year: 2022
cash: 8.2000
balanceSheetTotal: 22.3000
liabilities: 26.5000
totalShareholdersEquity: -4.1500
sales: 11.2700
investment: 1.2000
incomeBeforeTaxes: -6.4000
netIncome: -6.4000
employees: 49
currencyID: 1
units: 1000000
currency: EUR
year: 2023
cash: 2.5800
balanceSheetTotal: 14.6100
liabilities: 24.7400
totalShareholdersEquity: -10.1300
sales: 9.1800
investment: 0.8600
incomeBeforeTaxes: -6.7900
netIncome: -6.7940
employees: 52
currencyID: 1
units: 1000000
currency: EUR

Finanzen (ausführlich)

year: 2022 units: 1000000
balanceSheetTotal: 22.3000 cash: 8.2000
currentAssets: 14.3000 liabilities: 6.0000
nonCurrentLiabilities: 20.5000 totalLiabilitiesEquity: 22.3000
totalShareholdersEquity: -4.1500 employees: 49
property: 6.2000 intangibleAssets: 1.8000
inventories: 1.6000 accountsReceivable: 4.5200
accountsPayable: 1.2000 liabilitiesTotal: 26.5000
longTermDebt: 20.1800 shortTermDebt: 2.4400
minorityInterests: 0.0000 sales: 11.2700
depreciation: 0.7000 netIncome: -6.4000
operatingResult: -4.9100 incomeInterest: -1.5000
incomeTaxes: 0.0060 costGoodsSold: 14.0000
grossProfit: -2.7300 revenuePerEmployee: 230000.0000
cashFlow: -5.2000 cashFlowInvesting: -0.2000
cashFlowFinancing: 7.8000 accountingStandard: IFRS
equityRatio: -18.6099 liquidityI: 136.6667
liquidityII: 212.0000 netMargin: -56.7879
grossMargin: -24.2236 cashFlowMargin: -46.1402
ebitMargin: -43.5670 ebitdaMargin: 0.0000
preTaxROA: -28.6996 roa: -28.6996
netIncomeGrowth: 8.4746 revenuesGrowth: -2.8448
taxExpenseRate: -0.0937 epsBasic: -4.3000
epsBasicGrowth: 7.5000 priceCashFlowRatio: -16.3361
bookValuePerShare: -2.7553 marketCap: 84947536.8000
earningsYield: -7.6241 cashFlowPerShare: -3.4525
netAssetsPerShare: -2.7553 priceBookValueRatio: -20.4693
netEarningsPerShare: -4.2492 currency: EUR
year: 2023 units: 1000000
balanceSheetTotal: 14.6100 cash: 2.5800
currentAssets: 7.1300 fixedAssets: 7.4700
liabilities: 9.6500 nonCurrentLiabilities: 15.0900
totalLiabilitiesEquity: 14.6100 totalShareholdersEquity: -10.1300
employees: 52 property: 5.9400
intangibleAssets: 1.5200 inventories: 1.0100
accountsReceivable: 3.5300 accountsPayable: 1.5300
liabilitiesTotal: 24.7400 longTermDebt: 14.8400
shortTermDebt: 6.9500 sales: 9.1800
depreciation: 0.6780 netIncome: -6.7940
operatingResult: -5.1200 incomeInterest: 3.3800
incomeTaxes: 0.0040 minorityInterestsProfit: 0.0000
revenuePerEmployee: 176538.4615 cashFlow: -4.5200
cashFlowInvesting: -0.1280 cashFlowFinancing: -0.9290
accountingStandard: IFRS equityRatio: -69.3361
liquidityI: 26.7358 liquidityII: 63.3161
netMargin: -74.0087 cashFlowMargin: -49.2375
ebitMargin: -55.7734 ebitdaMargin: 0.0000
preTaxROA: -46.4750 roa: -46.5024
netIncomeGrowth: 6.1562 revenuesGrowth: -18.5448
taxExpenseRate: -0.0589 epsBasic: -4.5000
epsBasicGrowth: 4.6512 priceCashFlowRatio: -9.8078
bookValuePerShare: -6.6724 marketCap: 44331264.8000
earningsYield: -15.4110 cashFlowPerShare: -2.9772
priceBookValueRatio: -4.3762 netEarningsPerShare: -4.4751
currency: EUR
year: 2024 priceCashFlowRatio: -4.8199
bookValuePerShare: -6.6724 marketCap: 21786084.4792
earningsYield: -31.3589 pegRatio: -0.6856
cashFlowPerShare: -2.9772 netAssetsPerShare: -6.6724
priceBookValueRatio: -2.1506 netEarningsPerShare: -4.4751
currency: EUR

Finanzen (ausführlich)

year: 2022
units: 1000000
balanceSheetTotal: 22.3000
cash: 8.2000
currentAssets: 14.3000
liabilities: 6.0000
nonCurrentLiabilities: 20.5000
totalLiabilitiesEquity: 22.3000
totalShareholdersEquity: -4.1500
employees: 49
property: 6.2000
intangibleAssets: 1.8000
inventories: 1.6000
accountsReceivable: 4.5200
accountsPayable: 1.2000
liabilitiesTotal: 26.5000
longTermDebt: 20.1800
shortTermDebt: 2.4400
minorityInterests: 0.0000
sales: 11.2700
depreciation: 0.7000
netIncome: -6.4000
operatingResult: -4.9100
incomeInterest: -1.5000
incomeTaxes: 0.0060
costGoodsSold: 14.0000
grossProfit: -2.7300
revenuePerEmployee: 230000.0000
cashFlow: -5.2000
cashFlowInvesting: -0.2000
cashFlowFinancing: 7.8000
accountingStandard: IFRS
equityRatio: -18.6099
liquidityI: 136.6667
liquidityII: 212.0000
netMargin: -56.7879
grossMargin: -24.2236
cashFlowMargin: -46.1402
ebitMargin: -43.5670
ebitdaMargin: 0.0000
preTaxROA: -28.6996
roa: -28.6996
netIncomeGrowth: 8.4746
revenuesGrowth: -2.8448
taxExpenseRate: -0.0937
epsBasic: -4.3000
epsBasicGrowth: 7.5000
priceCashFlowRatio: -16.3361
bookValuePerShare: -2.7553
marketCap: 84947536.8000
earningsYield: -7.6241
cashFlowPerShare: -3.4525
netAssetsPerShare: -2.7553
priceBookValueRatio: -20.4693
netEarningsPerShare: -4.2492
currency: EUR
year: 2023
units: 1000000
balanceSheetTotal: 14.6100
cash: 2.5800
currentAssets: 7.1300
fixedAssets: 7.4700
liabilities: 9.6500
nonCurrentLiabilities: 15.0900
totalLiabilitiesEquity: 14.6100
totalShareholdersEquity: -10.1300
employees: 52
property: 5.9400
intangibleAssets: 1.5200
inventories: 1.0100
accountsReceivable: 3.5300
accountsPayable: 1.5300
liabilitiesTotal: 24.7400
longTermDebt: 14.8400
shortTermDebt: 6.9500
sales: 9.1800
depreciation: 0.6780
netIncome: -6.7940
operatingResult: -5.1200
incomeInterest: 3.3800
incomeTaxes: 0.0040
minorityInterestsProfit: 0.0000
revenuePerEmployee: 176538.4615
cashFlow: -4.5200
cashFlowInvesting: -0.1280
cashFlowFinancing: -0.9290
accountingStandard: IFRS
equityRatio: -69.3361
liquidityI: 26.7358
liquidityII: 63.3161
netMargin: -74.0087
cashFlowMargin: -49.2375
ebitMargin: -55.7734
ebitdaMargin: 0.0000
preTaxROA: -46.4750
roa: -46.5024
netIncomeGrowth: 6.1562
revenuesGrowth: -18.5448
taxExpenseRate: -0.0589
epsBasic: -4.5000
epsBasicGrowth: 4.6512
priceCashFlowRatio: -9.8078
bookValuePerShare: -6.6724
marketCap: 44331264.8000
earningsYield: -15.4110
cashFlowPerShare: -2.9772
priceBookValueRatio: -4.3762
netEarningsPerShare: -4.4751
currency: EUR
year: 2024
priceCashFlowRatio: -4.8199
bookValuePerShare: -6.6724
marketCap: 21786084.4792
earningsYield: -31.3589
pegRatio: -0.6856
cashFlowPerShare: -2.9772
netAssetsPerShare: -6.6724
priceBookValueRatio: -2.1506
netEarningsPerShare: -4.4751
currency: EUR